Robin Hardwicke, Ph.D., Assistant Professor of Medicine, University of Texas Health Science Center, Houston.

Previous articleCanterbury Health Laboratories to Leverage NimbleGen Microarray Cytogenetics Solution
Next articleRoche to Slash 4,800 Jobs to Save CHF 2.4B a Year